JP2024534118A5 - - Google Patents
Info
- Publication number
- JP2024534118A5 JP2024534118A5 JP2024511975A JP2024511975A JP2024534118A5 JP 2024534118 A5 JP2024534118 A5 JP 2024534118A5 JP 2024511975 A JP2024511975 A JP 2024511975A JP 2024511975 A JP2024511975 A JP 2024511975A JP 2024534118 A5 JP2024534118 A5 JP 2024534118A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- heavy chain
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163237104P | 2021-08-25 | 2021-08-25 | |
| US63/237,104 | 2021-08-25 | ||
| PCT/US2022/075438 WO2023028543A2 (en) | 2021-08-25 | 2022-08-25 | Anti-her2 antibodies and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534118A JP2024534118A (ja) | 2024-09-18 |
| JP2024534118A5 true JP2024534118A5 (cg-RX-API-DMAC7.html) | 2025-09-01 |
Family
ID=85322213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024511975A Pending JP2024534118A (ja) | 2021-08-25 | 2022-08-25 | 抗ｈｅｒ２抗体及びその使用方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20250136713A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4392458A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024534118A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240052019A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117980342A (cg-RX-API-DMAC7.html) |
| AR (1) | AR126873A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022333088A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3229542A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL311003A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024002406A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202328186A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023028543A2 (cg-RX-API-DMAC7.html) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7097840B2 (en) * | 2000-03-16 | 2006-08-29 | Genentech, Inc. | Methods of treatment using anti-ErbB antibody-maytansinoid conjugates |
| AU2014357292B2 (en) * | 2013-11-27 | 2020-06-25 | Zymeworks Bc Inc. | Bispecific antigen-binding constructs targeting HER2 |
| SG11201608192SA (en) * | 2014-04-11 | 2016-10-28 | Medimmune Llc | Bispecific her2 antibodies |
| EP3609580A4 (en) * | 2017-04-09 | 2021-03-24 | Combio Pharmaceutical, Inc. | COMMON LIGHT CHAIN BIPARATOPIC AND MULTIPARATOPIC ANTIBODIES AND METHOD OF USE |
-
2022
- 2022-08-25 WO PCT/US2022/075438 patent/WO2023028543A2/en not_active Ceased
- 2022-08-25 AU AU2022333088A patent/AU2022333088A1/en active Pending
- 2022-08-25 IL IL311003A patent/IL311003A/en unknown
- 2022-08-25 TW TW111132034A patent/TW202328186A/zh unknown
- 2022-08-25 EP EP22862264.3A patent/EP4392458A4/en active Pending
- 2022-08-25 CN CN202280057349.1A patent/CN117980342A/zh active Pending
- 2022-08-25 MX MX2024002406A patent/MX2024002406A/es unknown
- 2022-08-25 US US18/685,587 patent/US20250136713A1/en active Pending
- 2022-08-25 JP JP2024511975A patent/JP2024534118A/ja active Pending
- 2022-08-25 AR ARP220102290A patent/AR126873A1/es unknown
- 2022-08-25 KR KR1020247009991A patent/KR20240052019A/ko active Pending
- 2022-08-25 CA CA3229542A patent/CA3229542A1/en active Pending
-
2025
- 2025-10-08 US US19/352,786 patent/US20260109781A1/en active Pending